Cellular immunity aberrations in patients with SLE are underscored by the abnormal early Ag receptor-mediated lymphocyte signal transduction pathway. To further characterize the T cell receptor (TCR)/CD3-initiated signaling defects, we studied 22 patients with SLE, 12 patients with other systemic rheumatic diseases, and 14 normal donors. The early (1 min) TCR/CD3-mediated tyrosine phosphorylation of cellular proteins with a molecular size between 36 and 64 kD was increased in 15 of 21 SLE patients, compared to normal or disease control subjects. The deficiency or absence of a band with a molecular size of approximately 16 kD in the immunoblots of SLE patients led us to investigate the expression of the TCRzeta chain. In immunoblots using anti-zeta antibodies we found that 10 of 22 lupus patients tested lacked the expression of TCRzeta, which was always present in control subjects (P < 0.001). Flow cytometric studies using permeabilized cells confirmed the deficiency or absence of the TCRzeta chain in lupus T cells. Using Northern blots we found that for eight patients tested, the TCRzeta mRNA was missing in three, decreased in three, and apparently normal in two patients (P < 0.003), but was always present in control subjects. Reverse transcriptase-PCR verified Northern blot results. We conclude that TCRzeta chain expression is either decreased or absent in the majority of patients with SLE, but not in patients with other systemic rheumatic diseases, regardless of disease activity, treatment status, or clinical manifestations. The previously described increases in TCR-initiated Ca2+ responses and the herein described increases in TCR-induced protein tyrosine phosphorylation and deficient TCRzeta expression may represent intrinsic defects modulating lupus T cell function.
S N Liossis, X Z Ding, G J Dennis, G C Tsokos
Title and authors | Publication | Year |
---|---|---|
The problem of accelerated atherosclerosis in systemic lupus erythematosus: Insights into a complex co-morbidity :
NS Wade, AS Major |
Thrombosis and Haemostasis | 2011 |
Harnessing programmed cell death as a therapeutic strategy in rheumatic diseases
M Ramaswamy, M Deng, RM Siegel |
Nature reviews. Rheumatology | 2011 |
Abnormalities of T cell signaling in systemic lupus erythematosus
VR Moulton, GC Tsokos |
Arthritis Research & Therapy | 2011 |
Targeting lymphocyte signaling pathways as a therapeutic approach to systemic lupus erythematosus
VC Kyttaris, GC Tsokos |
Current Opinion in Rheumatology | 2011 |
SLAMF6-driven co-stimulation of human peripheral T cells is defective in SLE T cells
M Chatterjee, K Kis-Toth, TH Thai, C Terhorst, GC Tsokos |
Autoimmunity | 2011 |
Tumor-dependent down-regulation of the ζ-chain in T-cells is detectable in early breast cancer and correlates with immune cell function
JD Boniface, I Poschke, Y Mao, R Kiessling |
International Journal of Cancer | 2011 |
Tissue-Specific Expression of Human Calcineurin-Binding Protein 1 in Mouse Synovial Tissue Can Suppress Inflammatory Arthritis
DH Yu, JK Yi, SJ Park, MO Kim, HJ Kim, HS Yuh, KB Bae, YR Ji, HS Lee, SG Lee, YS Choo, JY Kim, DH Yoon, BH Hyun, ZY Ryoo |
Journal of Interferon & Cytokine Research | 2011 |
Development of unique antibodies directed against each of the six different phosphotyrosine residues within the T cell receptor CD3ζ chain
S Gelkop, B Weisman, RN Pulak, D Zharhary, N Isakov |
Journal of Immunological Methods | 2011 |
Linker for activation of t cells is displaced from lipid rafts and decreases in lupus t cells after activation via the tcr/cd3 pathway
N Abdoel, S Brun, C Bracho, MA Rodríguez, AM Blasini |
Clinical Immunology | 2011 |
Biologic Agents in the Treatment of Systemic Lupus Erythematosus
VC Kyttaris |
Systemic Lupus Erythematosus | 2011 |
T-Cells and Systemic Lupus Erythematosus
JC Crispín, GC Tsokos |
Systemic Lupus Erythematosus | 2011 |
Galectin-1-induced down-regulation of T lymphocyte activation protects (NZB x NZW) F1 mice from lupus-like disease
SD Liu, S Lee, AL Cava, CC Motran, BH Hahn, MC Miceli |
Lupus | 2011 |
A systemic lupus erythematosus gene expression array in disease diagnosis and classification: a preliminary report
YT Juang, C Peoples, R Kafri, VC Kyttaris, K Sunahori, K Kis-Toth, L Fitzgerald, S Ergin, M Finnell, GC Tsokos |
Lupus | 2011 |
Expression and function of Cbl-b in T cells from patients with systemic lupus erythematosus, and detection of the 2126 A/G Cblb gene polymorphism in the Mexican mestizo population
L Doníz-Padilla, V Martínez-Jiménez, P Niño-Moreno, C Abud-Mendoza, B Hernández-Castro, R González-Amaro, E Layseca-Espinosa, L Baranda-Cándido |
Lupus | 2011 |